We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 25 NOVEMBER 2013
New FTC Rules For Exclusive Pharmaceutical Patent Licenses
Foley & Lardner LLP
The Federal Trade Commission (FTC) has issued final rules under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) relating to the transfer of exclusive patent rights in the pharmaceutical industry.
United StatesIntellectual Property









